Xconomy Xchange: Boston's Life Science Disruptors
10.8.2014  AGENDA
 .
5:00 – 6:00 Registration
6:00 – 6:10 Welcome
Bob Buderi, Founder and Editor in Chief, Xconomy
Martin Seidel
, Global Head of Strategic Alliances, Novartis
6:15 – 6:40 Zafgen Story
Peter Barrett, Partner, Atlas Venture
Bruce Booth, Partner, Atlas Venture
Tom Hughes, CEO, Zafgen
6:40 – 7:05 Epizyme Story
Robert J. Gould, CEO, Epizyme
Carl Goldfischer, Managing Director, Bay City Capital
7:05 – 7:30 SAGE Therapeutics Story
Jeffrey Jonas, CEO, SAGE Therapeutics
Kevin Starr, Partner, Third Rock Ventures
7:30 – 8:30 Networking Reception
 .